A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
Epilepsy, Childhood Absence Epilepsy, Seizures
About this trial
This is an interventional treatment trial for Epilepsy focused on measuring Keppra, Epilepsy, Childhood Absence Epilepsy, Seizures
Eligibility Criteria
Inclusion Criteria: CAE by EEG criteria Naive to antiepileptics Onset 3 to 10 years old A history of daily seizures Age between 4 and 10 Weight at least 5th percentile for age Be able to take oral medications Be willing to return for diagnostic testing and visits and adhere to medication regime Exclusion Criteria: An EEG with any of the following abnormalities Focal epilepsy Slow spike and wave discharges Photoconvulsive response Slow background rhythms for age Currently being treated with an antiepileptic drug (AED) History of MR A history of myoclonic, atonic,tonic or astatic seizures A clinically unstable disease
Sites / Locations
- The Cleveland Clinic Foundation
- The Cleveland Clinic